game changer
ARLINGTON, Texas (AP) — The roof at the home of the Dallas Cowboys opened without incident and will stay that way for a Monday night meeting with the Cincinnati Bengals. It was to be the first game with the roof open at AT&T Stadium since Oct. 30, 2022, a 49-29 Dallas victory over Chicago. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
(Bloomberg) -- Republican Senator Joni Ernst, a key player in the struggle over Pete Hegseth’s confirmation as defense secretary, offered a boost on Monday to President-elect Donald Trump’s embattled nominee. “As I support Pete through this process, I look forward to a fair hearing based on truth, not anonymous sources,” Ernst said in a statement after meeting with Hegseth. Hegseth’s nomination is mired in allegations of sexual misconduct along with accusations of alcohol abuse and mismanagement of two veterans organizations. Ernst, a combat veteran and rape survivor who is an influential voice on military matters in the Senate, has pointedly declined to support Hegseth after meeting with him last week. But her noncommittal statements angered many conservatives and provoked threats of launching a primary challenge against her in two years. Her statement Monday fell short of signaling a vote in favor of his nomination but it conveyed public encouragement for continuing to seek confirmation. “I am supporting the process,” Ernst told reporters when asked if she would vote in favor of Hegseth’s appointment. She called the meeting very productive. “He does respect that I’m taking the time.” Trump’s team was said to be examining alternative candidates for the position last week as Hegseth came under criticism. But Trump defended Hegseth in a social media post late in the week and in an NBC interview. Hegseth “is a very smart guy,” Trump said in an interview for Sunday’s edition of NBC’s “Meet the Press.” “He loves the military and I think people are starting to see it, so we’ll be working on his nomination.” Hegseth is set to meet with Susan Collins and Lisa Murkowski later this week - two other potential holdouts. He can lose no more than three Republican votes and win confirmation given Republicans will have 53 votes and the tie-breaking vote of the vice president. Hegseth, a former Fox News host, is facing allegations that he raped a woman in 2017, a claim he has repeatedly denied. He was not charged after the allegation, but paid the accuser a financial settlement. A lawyer for Hegseth had said the encounter was consensual. The New Yorker also detailed his resignation from two veterans advocacy groups. The magazine highlighted a 2015 whistleblower report that described Hegseth as intoxicated on the job as president of Concerned Veterans for America and alleged that he and members of his management team pursued sexual relationships with the group’s female staff. Years earlier, another veterans’ advocacy group Hegseth also ran closed amid allegations of financial mismanagement. Hegseth and other contentious choices by Trump drew more attention following former Representative Matt Gaetz’s withdrawal from consideration to lead the Justice Department after he was scrutinized for alleged sexual misconduct. Also in the spotlight are vaccine skeptic Robert F. Kennedy Jr. to lead the Heath and Human Services Department; Tulsi Gabbard who was accused of being a Russian sympathizer, to run national intelligence, and Kash Patel to head the Federal Bureau of Investigation. Ernst also met with Patel and Gabbard on Monday and backed their nominations. Hegseth, a former Army National Guard officer who had served in Iraq and Afghanistan, has also repeatedly opposed women in combat. That stance puts him at odds with Ernst, whose daughter serves in the Army. Ernst sometimes criticized Trump, including in 2017 when she opposed a plan to ban trans members of the military, but has generally voted for his agenda and nominees. Ernst helped lead a bipartisan push to combat sexual assault in the military. In 2019, she told Bloomberg she was raped in college and later physically abused by her ex-husband. (Updates with additional detail beginning with fifth paragraph) More stories like this are available on bloomberg.com ©2024 Bloomberg L.P.W. Michigan 26, Eastern Michigan 18OneDigital Investment Advisors LLC acquired a new position in shares of Insmed Incorporated ( NASDAQ:INSM – Free Report ) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 3,181 shares of the biopharmaceutical company’s stock, valued at approximately $232,000. Several other large investors have also made changes to their positions in INSM. Kennedy Capital Management LLC acquired a new stake in Insmed during the first quarter worth about $267,000. Russell Investments Group Ltd. raised its holdings in Insmed by 15,915.2% in the first quarter. Russell Investments Group Ltd. now owns 22,101 shares of the biopharmaceutical company’s stock valued at $600,000 after buying an additional 21,963 shares during the period. TimesSquare Capital Management LLC acquired a new position in Insmed during the third quarter valued at approximately $35,322,000. &PARTNERS acquired a new position in Insmed during the second quarter valued at approximately $300,000. Finally, Natixis purchased a new stake in Insmed during the first quarter worth approximately $191,000. Insider Activity In related news, insider Martina M.D. Flammer sold 13,436 shares of the business’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $74.92, for a total transaction of $1,006,625.12. Following the completion of the sale, the insider now owns 106,134 shares of the company’s stock, valued at $7,951,559.28. This represents a 11.24 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink . Also, insider Orlov S. Nicole Schaeffer sold 37,575 shares of Insmed stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $71.50, for a total value of $2,686,612.50. Following the completion of the transaction, the insider now owns 100,100 shares of the company’s stock, valued at approximately $7,157,150. The trade was a 27.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here . In the last ninety days, insiders sold 78,882 shares of company stock worth $5,765,446. 4.60% of the stock is currently owned by insiders. Insmed Price Performance Insmed ( NASDAQ:INSM – Get Free Report ) last announced its quarterly earnings data on Thursday, October 31st. The biopharmaceutical company reported ($1.27) earnings per share for the quarter, missing the consensus estimate of ($1.19) by ($0.08). The company had revenue of $93.40 million during the quarter, compared to analysts’ expectations of $93.36 million. During the same period in the prior year, the company posted ($1.10) earnings per share. The firm’s revenue was up 18.1% compared to the same quarter last year. As a group, research analysts anticipate that Insmed Incorporated will post -5.42 earnings per share for the current fiscal year. Analyst Upgrades and Downgrades Several research firms recently weighed in on INSM. Bank of America lifted their target price on shares of Insmed from $84.00 to $86.00 and gave the company a “buy” rating in a report on Wednesday, October 9th. TD Cowen boosted their price objective on Insmed from $75.00 to $98.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. UBS Group increased their target price on Insmed from $78.00 to $84.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Truist Financial reissued a “buy” rating and set a $105.00 price target (up from $100.00) on shares of Insmed in a research report on Friday, November 1st. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $90.00 price objective on shares of Insmed in a research report on Friday, November 1st. One equities research analyst has rated the stock with a sell rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $83.67. Get Our Latest Stock Analysis on Insmed Insmed Company Profile ( Free Report ) Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed’s first commercial product is ARIKAYCE® (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. See Also Receive News & Ratings for Insmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insmed and related companies with MarketBeat.com's FREE daily email newsletter .
Gary Lineker has brutally told Micah Richards he will not be replacing him as the presenter of Match of the Day . It was announced earlier this month that Lineker would be stepping down at the end of the season after 25 years. Since the news emerged, a number of names have been linked with the role, including experienced presenters Mark Chapman , Gabby Logan , Alex Scott and Kelly Somers . Several ex-footballers have also been mooted as potential replacements, including current Match of the Day pundits Richards and Alan Shearer . Richards and Shearer also appear alongside Lineker on The Rest Is Football podcast and the trio have regularly discussed the future of the show. On a recent episode, Richards attempted to rule himself out of the running to replace Lineker and was hilariously shut down by the former England striker. "You know what, can I just get this out there, right," Richards began. "When people are saying Micah Richards is potentially going to take over a presenter, I think it's a massive disrespect to all the presenters out there. There's so many talented people. Just because I'm a pundit, I can give insight to a player, I feel I know the game, I watch tactics. "But to take over presenting one of the most iconic shows, not just in sport, but that BBC's ever had? There's so many others they can pick over me, I just can't believe they would even put my name in the hat." Lineker then jokingly replied: "Micah, you can totally relax. I can assure you they won't be asking you." Lineker has also refused to give his thoughts on who he feels should replace him, but he has shared some advice for his future successor. "Obviously, I don't know who it'll be, and I would never tell publicly my preference," he said. "I don't think that’d be the right thing to do – but whoever it is, I would say be yourself. I had to fill the ginormous shoes of certain Des Lynam. I would say just be yourself and enjoy it, it's a wonderful programme to be a part of. It was brilliant before I took over, and it will be brilliant after I leave." Join our new WhatsApp community and receive your daily dose of Mirror Football content. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. If you're curious, you can read our Privacy Notice. Sky has slashed the price of its Sky Sports, Sky Stream, Sky TV and Netflix bundle in an unbeatable new deal that saves £240 and includes 1,400 live matches across the Premier League, EFL and more.Rhode Island beats Bryant 35-21 to claim its first Coastal Athletic Association title
Alpine’s Pulling clinches F1 Academy title with round to spare
Gus Johnson Goes Viral for Hilarious Interception Call in Ohio State-Michigan Game